Ignite Creation Date:
2025-12-24 @ 7:18 PM
Ignite Modification Date:
2025-12-25 @ 4:57 PM
Study NCT ID:
NCT01616303
Status:
COMPLETED
Last Update Posted:
2020-09-14
First Post:
2012-05-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
Sponsor:
Quest PharmaTech Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-06-15
Start Date Type:
ACTUAL
Primary Completion Date:
2015-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-12
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-30
First Submit QC Date:
None
Study First Post Date:
2012-06-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-02-17
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-09-11
Last Update Post Date:
2020-09-14
Last Update Post Date Type:
ACTUAL